AbstractWe performed a retrospective study to identify pretransplantation risk factors for steroid-refractory (SR) acute graft-versus host disease (aGVHD) after allogeneic stem cell transplantation from matched donors in 630 adult patients who underwent transplantation at our center between 2000 and 2012. The cumulative incidence (CI) of SR aGVHD was 11.3% ± 2.3%. The identified independent risk factors were matched unrelated donor (hazard ratio [HR], 2.52; P = .001), female donor for male recipient (HR, 1.84; P = .023) and absence of antithymocyte globulin (HR, 2.02; P = .005). Three risk groups were defined according to the presence of these risk factors. In the whole cohort, the CI of SR aGVHD was 3.5% ± 1.7% in the low-risk group (0 ris...
AbstractThe optimal therapy for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is u...
AbstractAmong 810 consecutive hematopoietic stem cell transplantation (HSCT) patients, 679 survived ...
AbstractAcute renal failure (ARF) is a life-threatening complication after allogeneic stem cell tran...
AbstractWe performed a retrospective study to identify pretransplantation risk factors for steroid-r...
AbstractTo develop a novel acute graft-versus-host disease (GVHD) risk score, we examined the GVHD c...
Several prognostic factors for the outcome after allogeneic hematopoietic stem-cell transplant (HSCT...
We evaluated demographic characteristics and graft compo-sition as risk factors for acute graft-vers...
AbstractAllogeneic hematopoietic cell transplantation is often complicated by graft-versus-host dise...
International audienceRisk factors for acute GVHD (AGVHD), overall survival, and transplant-related ...
AbstractGlucocorticoids remain the standard approach to initial systemic management of acute graft-v...
AbstractConventional preparative regimens for allogeneic stem cell transplantation are associated wi...
AbstractManifestations of and risk factors for graft-versus-host disease (GVHD) after double-unit co...
AbstractMultivariate analysis was performed to determine the independent factors affecting the risk ...
AbstractAcute GVHD remains a major cause of morbidity and mortality after allogeneic hematopoietic s...
Anti-Tumor Necrosis Factor Alpha (TNF-α) therapy with infliximab has shown to be effective for patie...
AbstractThe optimal therapy for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is u...
AbstractAmong 810 consecutive hematopoietic stem cell transplantation (HSCT) patients, 679 survived ...
AbstractAcute renal failure (ARF) is a life-threatening complication after allogeneic stem cell tran...
AbstractWe performed a retrospective study to identify pretransplantation risk factors for steroid-r...
AbstractTo develop a novel acute graft-versus-host disease (GVHD) risk score, we examined the GVHD c...
Several prognostic factors for the outcome after allogeneic hematopoietic stem-cell transplant (HSCT...
We evaluated demographic characteristics and graft compo-sition as risk factors for acute graft-vers...
AbstractAllogeneic hematopoietic cell transplantation is often complicated by graft-versus-host dise...
International audienceRisk factors for acute GVHD (AGVHD), overall survival, and transplant-related ...
AbstractGlucocorticoids remain the standard approach to initial systemic management of acute graft-v...
AbstractConventional preparative regimens for allogeneic stem cell transplantation are associated wi...
AbstractManifestations of and risk factors for graft-versus-host disease (GVHD) after double-unit co...
AbstractMultivariate analysis was performed to determine the independent factors affecting the risk ...
AbstractAcute GVHD remains a major cause of morbidity and mortality after allogeneic hematopoietic s...
Anti-Tumor Necrosis Factor Alpha (TNF-α) therapy with infliximab has shown to be effective for patie...
AbstractThe optimal therapy for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is u...
AbstractAmong 810 consecutive hematopoietic stem cell transplantation (HSCT) patients, 679 survived ...
AbstractAcute renal failure (ARF) is a life-threatening complication after allogeneic stem cell tran...